Archives rituxan

by in
Entry Author Date Location
Epizyme Shares Climb on New Data for Cancer Drug 06/22/15 Boston
It Had to be You: Why Roche Was The Lone Suitor For Foundation 01/16/15 Boston
East Coast Biotech Roundup: Unum, RaNA, Maxwell, Biogen, & More 12/05/14 Boston
With Souped-Up Rituxan, Unum Plots First Foray Into T-Cell Therapy 12/01/14 Boston
CF Foundation Cashes Out on Kalydeco in $3.3B Sale to Royalty Pharma 11/19/14 Boston
AbbVie Plunks Down $275M Upfront for Infinity’s Blood Cancer Drug 09/03/14 Boston
Military Strategies Being Used in the War on Cancer 08/04/14 Seattle
Gilead Edges Into Cancer Field With FDA OK of Calistoga Drug 07/23/14 San Francisco
Houston’s Capital Royalty Evolving in Healthcare Growth Financing 11/19/13 Texas
Genentech CMO Hal Barron Joins ‘Building Biotechs to Last’ Dec. 9 11/14/13 San Francisco
Genentech Does it Again, Wins FDA Approval for ‘Son of Rituxan’ 11/01/13 San Francisco
Gilead Seeks FDA OK for Lymphoma Drug, First Big Move into Cancer 09/11/13 San Francisco
Why Good Drugs Sometimes Fail: The Bexxar Story 08/26/13 National
Genentech Cancer Antibody, Son of Rituxan, Nails Pivotal Study 05/15/13 San Francisco
Former Keryx Exec’s Mission: Turn TG Into the Next Pharmacyclics 05/06/13 New York
Adimab Grows Up, Looks to Pay Off the VCs In Unusual Way 02/22/13 Boston
Third Rock’s Latest, Jounce, Grabs $47M For Cancer Immunotherapy 02/14/13 Boston
Life Science Innovation NW Notes: SeaGen, NanoString, Viket, & More 07/12/12 Seattle
ImmunoGen Emerges from Genentech’s Shadow With Novel Cancer Drugs 07/12/12 Boston
Seattle Genetics Sees Updated Side Effect Warning in Drug Label 01/13/12 Seattle
Seattle Genetics Sees Case of PML, Causing Market Twitch 12/01/11 Seattle
ImmunoGen CEO Highlights Two New Souped-Up Antibodies Against Cancer 02/25/11 Boston
Calistoga Rolls Out More Evidence For Blood Cancer Drug, Sizes Up Pivotal Trial 12/05/10 Seattle
Seattle Genetics, Millennium Report Groundbreaking Results With Drug for Hodgkin’s 12/05/10 Seattle
Dendreon’s Commercial Point Man Exits In Year One of Provenge Launch 11/18/10 Seattle
Roche Cuts to Hit Hundreds of Genentech Workers; Scientific Staff is Spared 11/17/10 San Francisco
Biogen Announces Restructuring, FDA Approves Sunovion Drug, Acceleron Cuts Workforce, & More Boston-Area Life Sciences News 11/05/10 Boston
Biogen Idec Axes 650 Jobs, Closes San Diego Site, Bets Future on Neurology 11/03/10 Boston
Alkermes Drops on FDA Rejection, Glaxo’s SR One Backs Dicerna, Biogen Reworks Genentech Alliance, & More Boston-Are Life Sciences News 10/22/10 Boston
Biogen, Genentech Revamp Alliance 10/21/10 San Francisco
Page 1 of 3 next page »